Accenture (ACN) Stock Forecast & Price Target

Q: What analysts cover Accenture?

Accenture has been rated by research analysts at Argus , BMO Capital Markets , Citigroup , Deutsche Bank Aktiengesellschaft , Evercore , Guggenheim , Jefferies Financial Group , JPMorgan Chase & Co. , Mizuho , Morgan Stanley , Robert W. Baird , Royal Bank Of Canada , Susquehanna , TD Cowen , The Goldman Sachs Group , Truist Financial , UBS Group , Weiss Ratings , Wells Fargo & Company , and Wolfe Research in the past 90 days.

$207.41 -0.95 (-0.46%)

As of 12:54 PM Eastern

Compare

Accenture - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 27 Analyst Ratings

Sell
2

Hold
14

Buy
11

Based on 27 Wall Street analysts who have issued ratings for Accenture in the last 12 months, the stock has a consensus rating of "Hold." Out of the 27 analysts, 2 have given a sell rating, 14 have given a hold rating, and 11 have given a buy rating for ACN.

Consensus Price Target

$219.15
5.66% Upside

According to the 27 analysts' twelve-month price targets for Accenture, the average price target is $219.15. The highest price target for ACN is $282.00, while the lowest price target for ACN is $130.00. The average price target represents a forecasted upside of 5.66% from the current price of $207.41.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ACN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Accenture and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACN Analyst Ratings Over Time

Type	Current Forecast 10/9/25 to 10/9/26	1 Month Ago 9/9/25 to 9/9/26	3 Months Ago 7/11/25 to 7/11/26	1 Year Ago 10/9/24 to 10/9/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	13 Buy rating(s)
Hold	14 Hold rating(s)	14 Hold rating(s)	14 Hold rating(s)	8 Hold rating(s)
Sell	2 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$219.15	$194.19	$193.19	$296.82
Forecasted Upside	5.66% Upside	10.45% Upside	42.90% Upside	17.65% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

ACN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ACN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Accenture Stock vs. The Competition

Type	Accenture	Technology Companies	Broader Market
Consensus Rating Score	2.33	2.23	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	4.99% Upside	643.16% Upside	19.63% Upside
News Sentiment Rating	Positive News See Recent ACN News	Neutral News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/6/2026	Weiss Ratings 3 of 5 stars		Reiterated Rating	Sell (D+)
10/6/2026	Mizuho 3 of 5 stars	Dan Dolev 1 of 5 stars	Boost Target	Outperform	$226.00 ➝ $241.00	+23.49%
10/2/2026	BMO Capital Markets 3 of 5 stars	Keith Bachman 1 of 5 stars	Set Target		$235.00	+16.28%
10/2/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kupferberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Reduce
10/2/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$220.00	+3.75%
10/2/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arvind Ramnani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$150.00 ➝ $220.00	+8.77%
10/2/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Paige Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$175.00 ➝ $240.00	+16.05%
10/2/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
10/2/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jim Kelleher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$220.00 ➝ $260.00	+22.61%
10/2/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$175.00 ➝ $195.00	-8.04%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date
10/1/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$230.00 ➝ $260.00	+22.61%
10/1/2026	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$153.00 ➝ $210.00	-0.97%
10/1/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$245.00	+15.54%
10/1/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Outperform	$250.00	+15.69%
10/1/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Bergin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$173.00 ➝ $193.00	-10.51%
9/30/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin McVeigh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
9/25/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tien-Tsin Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$179.00 ➝ $200.00	+12.40%
9/18/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nate Svensson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$136.00 ➝ $175.00	-4.61%
8/25/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Darrin Peller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$165.00 ➝ $215.00	+15.25%
8/24/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Keane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$135.00 ➝ $190.00	+2.17%
6/26/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Neutral	$180.00 ➝ $130.00	+2.11%
6/23/2026	Dbs Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Moderate Buy ➝ Hold
6/23/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$275.00 ➝ $175.00	+38.66%
6/18/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
6/17/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$273.00 ➝ $220.00	+32.66%
6/8/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$201.00	+12.63%
6/3/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$315.00 ➝ $270.00	+44.95%
4/14/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Hold	$220.00 ➝ $210.00	+9.44%
3/5/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$282.00	+33.31%
1/5/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harry Read Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$205.00 ➝ $210.00	-19.16%
6/23/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$390.00 ➝ $360.00	+24.14%
6/20/2025	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Mixed

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:54 PM ET.

Should I Buy Accenture Stock? ACN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 5, 2026. Please send any questions or comments about these Accenture pros and cons to contact@marketbeat.com.

Accenture
Bull Case

Here are some ways that investors could benefit from investing in Accenture:

Accenture recently reported fourth-quarter earnings that exceeded expectations, with actual earnings per share of $3.29 beating the consensus estimate of $3.18, and revenue of $18.68 billion surpassing the $18.03 billion consensus, demonstrating strong operational performance and resilience in enterprise technology spending.
The company provided a stronger-than-expected full-year revenue forecast for fiscal 2027, guiding for revenue between $76.4 billion and $78.7 billion, which helped lift sentiment in the IT sector and eased concerns that artificial-intelligence disruption could reduce enterprise technology spending.
Accenture offers an attractive valuation with a current stock price of $195.15 and a P/E ratio of 14.39, which is significantly lower than its 52-week high of $291.09, suggesting the stock may be undervalued relative to its historical performance and strong free cash flow generation.
Investors can benefit from a robust shareholder return program, as the company recently increased its quarterly dividend to $1.71 per share, representing a 3.5% yield, and has approved a $2.00 billion share buyback plan, indicating management confidence in the stock's value.
The company is actively expanding its capabilities through strategic acquisitions, such as the completion of the acquisition of Denmark-based Mjølner Informatics, which adds software-engineering capabilities for energy, utilities, and manufacturing clients, strengthening its industry expertise and European delivery platform.

Accenture
Bear Case

Investors should be bearish about investing in Accenture for these reasons:

Analysts have recently downgraded the stock's consensus rating to "Hold" with a target price of $200.04, reflecting a significant drop from previous "Moderate Buy" ratings and targets near $298, indicating growing uncertainty about the company's future growth trajectory.
Accenture faces significant exposure to international revenue trends, which creates vulnerability to foreign economies, currency fluctuations, and regional technology budget constraints, posing a risk to its financial stability and growth prospects.
There is ongoing concern that artificial intelligence could disrupt the traditional IT services model, with some analysts characterizing Accenture as a potential warning signal for broader enterprise IT spending, despite the company's efforts to pivot toward AI solutions.
Short interest in the stock has increased, with shares shorted rising to 24.8 million as of September 2026, and days to cover increasing to 5.54, suggesting that a growing number of investors are betting against the stock's performance.
Insider selling activity has been notable, with multiple executives, including the CEO and General Counsel, selling significant portions of their holdings in recent months, which may signal a lack of confidence in the stock's near-term upside potential.

ACN Forecast - Frequently Asked Questions

According to the research reports of 27 Wall Street equities research analysts, the average twelve-month stock price forecast for Accenture is $219.15, with a high forecast of $282.00 and a low forecast of $130.00.

27 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Accenture in the last year. There are currently 2 sell ratings, 14 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ACN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACN, but not buy additional shares or sell existing shares.

According to analysts, Accenture's stock has a predicted upside of 5.66% based on their 12-month stock forecasts.

Over the previous 90 days, Accenture's stock had 2 downgrades by analysts.

Accenture has been rated by research analysts at Argus, BMO Capital Markets, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore, Guggenheim, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Robert W. Baird, Royal Bank Of Canada, Susquehanna, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Weiss Ratings, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Accenture more than other "technology" companies. The consensus rating score for Accenture is 2.33 while the average consensus rating score for "technology" companies is 2.23. Learn more on how ACN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Accenture Recommendations

MarketBeat monitors more than a dozen sources for Accenture analyst ratings, with the most recent rating issued on 10/6/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Accenture (ACN) Stock Forecast & Price Target